Abstract
Gastric ulcer bleeding in an AHA patient with persistent inhibitor can be effectively stopped with endoscopic methods of hemostasis and appropriate dosing of rFVIIa. In the event of recurrent bleed-ing episodes the treatment should be repeated several times, in or-der to minimize indications to surgical treatment as far as possible. Surgery in AHA patients with persistent inhibitor must be avoid-ed due to the risk of uncontrolled fatal bleeding; it should only be undertaken in immediately life-threatening situations.</BR> </BR>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have